Company intelligence / Profile preview
AfaSci, Inc.
Burlingame, California, United Statesafasci.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
All current therapeutic candidates are at the preclinical stage. Two lead programs for neuropathic and neuroinflammatory pain are ready for IND-enabling studies. The company’s research has been validated by NIH grants and peer-reviewed publications. No active clinical trials are registered as of now.
- Therapeutic areas
- Neurology
- Modalities
- PeptidesSmall molecules
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
Academic collaborations with Stanford University, Harvard University, UCLA, UC Davis, Kansas State University
Beyond the preview
Go deeper on AfaSci, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AfaSci, Inc..